Annexin A2 Enhances complement activation by inhibiting factor H

Journal of Immunology

Volumn 196, Issue 3, 2016, Pages 1355-1365

  Renner, Brandon ^a   Tong, Hua Hua ^b   Laskowski, Jennifer ^a   Jonscher, Karen ^a   Goetz, Lindsey ^a   Woolaver, Rachel ^a   Hannan, Jonathan ^a   Li, Yong Xing ^b   Hourcade, Dennis ^c   Pickering, Matthew C ^d   Michael Holers, V ^a   Thurman, Joshua M ^a  

^a UNIVERSITY OF COLORADO SCHOOL OF MEDICINE   (United States)

^b OHIO STATE UNIVERSITY   (United States)

^c WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d IMPERIAL COLLEGE LONDON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

COMPLEMENT COMPONENT C3B; COMPLEMENT FACTOR H; LIPOCORTIN 2;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BACTERIAL CLEARANCE; CELL SURFACE; COMPLEMENT ACTIVATION; CONTROLLED STUDY; HUMAN; IMMUNOAFFINITY CHROMATOGRAPHY; IMMUNOPRECIPITATION; INHIBITION KINETICS; KIDNEY; LIQUID CHROMATOGRAPHY; MASS SPECTROMETRY; MOUSE; NONHUMAN; OTITIS MEDIA; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN EXPRESSION; PROTEIN PROTEIN INTERACTION; REGULATORY MECHANISM; SIGNAL TRANSDUCTION; STREPTOCOCCUS PNEUMONIAE; ACUTE KIDNEY FAILURE; ANIMAL; C57BL MOUSE; DISEASE MODEL; ENZYME LINKED IMMUNOSORBENT ASSAY; FLOW CYTOMETRY; FLUORESCENT ANTIBODY TECHNIQUE; IMMUNOHISTOCHEMISTRY; IMMUNOLOGY; REPERFUSION INJURY; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; WESTERN BLOTTING;

ACUTE KIDNEY INJURY; ANIMALS; ANNEXIN A2; BLOTTING, WESTERN; CHROMATOGRAPHY, LIQUID; COMPLEMENT ACTIVATION; COMPLEMENT FACTOR H; DISEASE MODELS, ANIMAL; ENZYME-LINKED IMMUNOSORBENT ASSAY; FLOW CYTOMETRY; FLUORESCENT ANTIBODY TECHNIQUE; IMMUNOHISTOCHEMISTRY; IMMUNOPRECIPITATION; MASS SPECTROMETRY; MICE; MICE, INBRED C57BL; OTITIS MEDIA; REPERFUSION INJURY; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION;

EID: 84957642167     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.1500793     Document Type: Article

References (62)

1. Meri, S., and M. K. Pangburn. 1990. Discrimination between activators and non - Activators of the alternative pathway of complement: regulation via a sialic acid/polyanion binding site on factor H. Proc. Natl. Acad. Sci. USA 87: 3982-3986.
2. Pickering, M. C., H. T. Cook, J. Warren, A. E. Bygrave, J. Moss, M. J. Walport, and M. Botto. 2002. Uncontrolled C3 activation causes membranoproliferative glomer-ulonephritis in mice deficient in complement factor H. Nat. Genet. 31: 424-428.
3. de Córdoba, S. R., and E. G. de Jorge. 2008. Translational mini-review series on complement factor H: genetics and disease associations of human complement factor H. Clin. Exp. Immunol. 151: 1-13.
4. Sethi, S., F. C. Fervenza, Y. Zhang, L. Zand, J. A. Vrana, S. H. Nasr, J. D. Theis, A. Dogan, and R. J. Smith. 2012. C3 glomerulonephritis: clinicopathological findings, complement abnormalities, glomerular proteomic profile, treatment, and follow-up. Kidney Int. 82: 465-473.
5. Servais, A., L. H. Noël, L. T. Roumenina, M. Le Quintrec, S. Ngo, M. A. Dragon-Durey, M. A. Macher, J. Zuber, A. Karras, F. Provot, et al. 2012. Acquired and genetic complement abnormalities play a critical role in dense deposit disease and other C3 glomerulopathies. Kidney Int. 82: 454-464.
6. Fremeaux-Bacchi, V., E. J. Kemp, J. A. Goodship, M. A. Dragon-Durey, L. Strain, C. Loirat, H. W. Deng, and T. H. Goodship. 2005. The development of atypical haemolytic-uraemic syndrome is influenced by susceptibility factors in factor H and membrane cofactor protein: evidence from two independent cohorts. J. Med. Genet. 42: 852-856.
7. Noris, M., P. Ruggenenti, A. Perna, S. Orisio, J. Caprioli, C. Skerka, B. Vasile, P. F. Zipfel, and G. Remuzzi. 1999. Hypocomplementemia discloses genetic predisposition to hemolytic uremic syndrome and thrombotic thrombocytopenic purpura: role of factor H abnormalities. Italian Registry of Familial and Recurrent Hemolytic Uremic Syndrome/Thrombotic Thrombocytopenic Purpura. J. Am. Soc. Nephrol. 10: 281-293.
8. Edwards, A. O., R. Ritter, III, K. J. Abel, A. Manning, C. Panhuysen, and L. A. Farrer. 2005. Complement factor H polymorphism and age-related macular degeneration. Science 308: 421-424.
9. Haines, J. L., M. A. Hauser, S. Schmidt, W. K. Scott, L. M. Olson, P. Gallins, K. L. Spencer, S. Y. Kwan, M. Noureddine, J. R. Gilbert, et al. 2005. Complement factor H variant increases the risk of age-related macular degeneration. Science 308: 419-421.
10. Klein, R. J., C. Zeiss, E. Y. Chew, J. Y. Tsai, R. S. Sackler, C. Haynes, A. K. Henning, J. P. SanGiovanni, S. M. Mane, S. T. Mayne, et al. 2005. Complement factor H polymorphism in age-related macular degeneration. Science 308: 385-389.
11. Hageman, G. S., D. H. Anderson, L. V. Johnson, L. S. Hancox, A. J. Taiber, L. I. Hardisty, J. L. Hageman, H. A. Stockman, J. D. Borchardt, K. M. Gehrs, et al. 2005. A common haplotype in the complement regulatory gene factor H (HF1/CFH) predisposes individuals to age-related macular degeneration. Proc. Natl. Acad. Sci. USA 102: 7227-7232.
12. Noris, M., J. Caprioli, E. Bresin, C. Mossali, G. Pianetti, S. Gamba, E. Daina, C. Fenili, F. Castelletti, A. Sorosina, et al. 2010. Relative role of genetic complement abnormalities in sporadic and familial aHUS and their impact on clinical phenotype. Clin. J. Am. Soc. Nephrol. 5: 1844-1859.
13. Thurman, J. M., D. Ljubanovic, C. L. Edelstein, G. S. Gilkeson, and V. M. Holers. 2003. Lack of a functional alternative complement pathway ameliorates ischemic acute renal failure in mice. J. Immunol. 170: 1517-1523.
14. Thurman, J. M., M. S. Lucia, D. Ljubanovic, and V. M. Holers. 2005. Acute tubular necrosis is characterized by activation of the alternative pathway of complement. Kidney Int. 67: 524-530.
15. Lenderink, A. M., K. Liegel, D. Ljubanović, K. E. Coleman, G. S. Gilkeson, V. M. Holers, and J. M. Thurman. 2007. The alternative pathway of complement is activated in the glomeruli and tubulointerstitium of mice with adriamycin nephropathy. Am. J. Physiol. Renal Physiol. 293: F555-F564.
16. Turnberg, D., M. Lewis, J. Moss, Y. Xu, M. Botto, and H. T. Cook. 2006. Complement activation contributes to both glomerular and tubulointerstitial damage in adriamycin nephropathy in mice. J. Immunol. 177: 4094-4102.
17. Xiao, H., A. Schreiber, P. Heeringa, R. J. Falk, and J. C. Jennette. 2007. Alternative complement pathway in the pathogenesis of disease mediated by anti-neutrophil cytoplasmic autoantibodies. Am. J. Pathol. 170: 52-64.
18. Xing, G. Q., M. Chen, G. Liu, P. Heeringa, J. J. Zhang, X. Zheng, J. E, C. G. Kallenberg, and M. H. Zhao. 2009. Complement activation is involved in renal damage in human antineutrophil cytoplasmic autoantibody associated pauci-immune vasculitis. J. Clin. Immunol. 29: 282-291.
19. Watanabe, H., G. Garnier, A. Circolo, R. A. Wetsel, P. Ruiz, V. M. Holers, S. A. Boackle, H. R. Colten, and G. S. Gilkeson. 2000. Modulation of renal disease in MRL/lpr mice genetically deficient in the alternative complement pathway factor B. J. Immunol. 164: 786-794.
20. Leffler, J., A. P. Herbert, E. Norström, C. Q. Schmidt, P. N. Barlow, A. M. Blom, and M. Martin. 2010. Annexin-II, DNA, and histones serve as factor H ligands on the surface of apoptotic cells. J. Biol. Chem. 285: 3766-3776.
21. Li, Q., Y. X. Li, K. Douthitt, G. L. Stahl, J. M. Thurman, and H. H. Tong. 2012. Role of the alternative and classical complement activation pathway in complement mediated killing against Streptococcus pneumoniae colony opacity variants during acute pneumococcal otitis media in mice. Microbes Infect. 14: 1308-1318.
22. Li, Q., Y. X. Li, G. L. Stahl, J. M. Thurman, Y. He, and H. H. Tong. 2011. Essential role of factor B of the alternative complement pathway in complement activation and opsonophagocytosis during acute pneumococcal otitis media in mice. Infect. Immun. 79: 2578-2585.
23. Thurman, J. M., L. Kulik, H. Orth, M. Wong, B. Renner, S. A. Sargsyan, L. M. Mitchell, D. E. Hourcade, J. P. Hannan, J. M. Kovacs, et al. 2013. Detection of complement activation using monoclonal antibodies against C3d. J. Clin. Invest. 123: 2218-2230.
24. Schwartz, N., M. Hosford, R. M. Sandoval, M. C. Wagner, S. J. Atkinson, J. Bamburg, and B. A. Molitoris. 1999. Ischemia activates actin depolymerizing factor: role in proximal tubule microvillar actin alterations. Am. J. Physiol. 276: F544-F551.
25. Kim, Y. U., T. Kinoshita, H. Molina, D. Hourcade, T. Seya, L. M. Wagner, and V. M. Holers. 1995. Mouse complement regulatory protein Crry/p65 uses the specific mechanisms of both human decay - Accelerating factor and membrane cofactor protein. J. Exp. Med. 181: 151-159.
26. Natsuume-Sakai, S., M. Okada, T. Seya, M. Nonaka, Y. Harada, and K. Moriwaki. 1991. The mouse factor H allotypes with multiple amino acid replacement, H.1 and H.2 show indistinguishable co-factor activity for factor I. Eur. J. Immunogenetics 18: 399-403.
27. Thurman, J. M., D. Ljubanović, P. A. Royer, D. M. Kraus, H. Molina, N. P. Barry, G. Proctor, M. Levi, and V. M. Holers. 2006. Altered renal tubular expression of the complement inhibitor Crry permits complement activation after ischemia/reperfusion. J. Clin. Invest. 116: 357-368.
28. Pangburn, M. K., K. L. Pangburn, V. Koistinen, S. Meri, and A. K. Sharma. 2000. Molecular mechanisms of target recognition in an innate immune system: interactions among factor H, C3b, and target in the alternative pathway of human complement. J. Immunol. 164: 4742-4751.
29. Hunt, D. F., J. R. Yates, III, J. Shabanowitz, S. Winston, and C. R. Hauer. 1986. Protein sequencing by tandem mass spectrometry. Proc. Natl. Acad. Sci. USA 83: 6233-6237.
30. Cheng, C. W., A. Rifai, S. M. Ka, H. A. Shui, Y. F. Lin, W. H. Lee, and A. Chen. 2005. Calcium-binding proteins annexin A2 and S100A6 are sensors of tubular injury and recovery in acute renal failure. Kidney Int. 68: 2694-2703.
31. Renner, B., K. Coleman, R. Goldberg, C. Amura, A. Holland-Neidermyer, K. Pierce, H. N. Orth, H. Molina, V. P. Ferreira, C. Cortes, et al. 2010. The complement inhibitors Crry and factor H are critical for preventing autologous complement activation on renal tubular epithelial cells. J. Immunol. 185: 3086-3094.
32. Thurman, J. M., D. M. Kraus, G. Girardi, D. Hourcade, H. J. Kang, P. A. Royer, L. M. Mitchell, P. C. Giclas, J. Salmon, G. Gilkeson, and V. M. Holers. 2005. A novel inhibitor of the alternative complement pathway prevents antiphospholipid antibody-induced pregnancy loss in mice. Mol. Immunol. 42: 87-97.
33. Ferreira, V. P., A. P. Herbert, H. G. Hocking, P. N. Barlow, and M. K. Pangburn. 2006. Critical role of the C-terminal domains of factor H in regulating complement activation at cell surfaces. J. Immunol. 177: 6308-6316.
34. Hakobyan, S., A. Tortajada, C. L. Harris, S. R. de Córdoba, and B. P. Morgan. 2010. Variant-specific quantification of factor H in plasma identifies null alleles associated with atypical hemolytic uremic syndrome. Kidney Int. 78: 782-788.
35. Luo, M., and K. A. Hajjar. 2013. Annexin A2 system in human biology: cell surface and beyond. Semin. Thromb. Hemost. 39: 338-346.
36. Gerke, V., and S. E. Moss. 2002. Annexins: from structure to function. Physiol. Rev. 82: 331-371.
37. Martin, M., J. Leffler, and A. M. Blom. 2012. Annexin A2 and A5 serve as new ligands for C1q on apoptotic cells. J. Biol. Chem. 287: 33733-33744.
38. Hajjar, K. A., C. A. Guevara, E. Lev, K. Dowling, and J. Chacko. 1996. Interaction of the fibrinolytic receptor, annexin II, with the endothelial cell surface. Essential role of endonexin repeat 2. J. Biol. Chem. 271: 21652-21659.
39. Hajjar, K. A., A. T. Jacovina, and J. Chacko. 1994. An endothelial cell receptor for plasminogen/tissue plasminogen activator. I. Identity with annexin II. J. Biol. Chem. 269: 21191-21197.
40. Malhotra, R., M. Ward, H. Bright, R. Priest, M. R. Foster, M. Hurle, E. Blair, and M. Bird. 2003. Isolation and characterisation of potential respiratory syncytial virus receptor(s) on epithelial cells. Microbes Infect. 5: 123-133.
41. Kirschnek, S., C. Adams, and E. Gulbins. 2005. Annexin II is a novel receptor for Pseudomonas aeruginosa. Biochem. Biophys. Res. Commun. 327: 900-906.
42. Cesarman-Maus, G., N. P. Ríos-Luna, A. B. Deora, B. Huang, R. Villa, Mdel. C. Cravioto, D. Alarcón-Segovia, J. Sánchez-Guerrero, and K. A. Hajjar. 2006. Autoantibodies against the fibrinolytic receptor, annexin 2, in anti-phospholipid syndrome. Blood 107: 4375-4382.
43. Yung, S., K. F. Cheung, Q. Zhang, and T. M. Chan. 2010. Anti-dsDNA antibodies bind to mesangial annexin II in lupus nephritis. J. Am. Soc. Nephrol. 21: 1912-1927.
44. Umeda, S., M. T. Suzuki, H. Okamoto, F. Ono, A. Mizota, K. Terao, Y. Yoshikawa, Y. Tanaka, and T. Iwata. 2005. Molecular composition of drusen and possible involvement of anti-retinal autoimmunity in two different forms of macular degeneration in cynomolgus monkey (Macaca fascicularis). FASEB J. 19: 1683-1685.
45. Sethi, S., J. D. Gamez, J. A. Vrana, J. D. Theis, H. R. Bergen, III, P. F. Zipfel, A. Dogan, and R. J. Smith. 2009. Glomeruli of Dense Deposit Disease contain components of the alternative and terminal complement pathway. Kidney Int. 75: 952-960.
46. Noris, M., and G. Remuzzi. 2009. Atypical hemolytic-uremic syndrome. N. Engl. J. Med. 361: 1676-1687.
47. Pickering, M. C., V. D. D'Agati, C. M. Nester, R. J. Smith, M. Haas, G. B. Appel, C. E. Alpers, I. M. Bajema, C. Bedrosian, M. Braun, et al. 2013. C3 glomerulopathy: consensus report. Kidney Int. 84: 1079-1089.
48. Le Quintrec, M., J. Zuber, B. Moulin, N. Kamar, M. Jablonski, A. Lionet, V. Chatelet, C. Mousson, G. Mourad, F. Bridoux, et al. 2013. Complement genes strongly predict recurrence and graft outcome in adult renal transplant recipients with atypical hemolytic and uremic syndrome. Am. J. Transplant. 13: 663-675.
49. Noris, M., and G. Remuzzi. 2010. Thrombotic microangiopathy after kidney transplantation. Am. J. Transplant. 10: 1517-1523.
50. Clark, S. J., L. A. Ridge, A. P. Herbert, S. Hakobyan, B. Mulloy, R. Lennon, R. Würzner, B. P. Morgan, D. Uhŕin, P. N. Bishop, and A. J. Day. 2013. Tissue-specific host recognition by complement factor H is mediated by differential activities of its glycosaminoglycan-binding regions. J. Immunol. 190: 2049-2057.
51. Goicoechea de Jorge, E., J. J. Caesar, T. H. Malik, M. Patel, M. Colledge, S. Johnson, S. Hakobyan, B. P. Morgan, C. L. Harris, M. C. Pickering, and S. M. Lea. 2013. Dimerization of complement factor H-related proteins modulates complement activation in vivo. Proc. Natl. Acad. Sci. USA 110: 4685-4690.
52. Tortajada, A., H. Yébenes, C. Abarrategui-Garrido, J. Anter, J. M. Garćia-Fernández, R. Martínez-Barricarte, M. Alba-Domínguez, T. H. Malik, R. Bedoya, R. Cabrera Pérez, et al. 2013. C3 glomerulopathy - Associated CFHR1 mutation alters FHR oligomerization and complement regulation. J. Clin. Invest. 123: 2434-2446.
53. Chen, Q., M. Wiesener, H. U. Eberhardt, A. Hartmann, B. Uzonyi, M. Kirschfink, K. Amann, M. Buettner, T. Goodship, C. Hugo, et al. 2014. Complement factor H-related hybrid protein deregulates complement in dense deposit disease. J. Clin. Invest. 124: 145-155.
54. Prosser, B. E., S. Johnson, P. Roversi, A. P. Herbert, B. S. Blaum, J. Tyrrell, T. A. Jowitt, S. J. Clark, E. Tarelli, D. Uhrín, et al. 2007. Structural basis for complement factor H linked age-related macular degeneration. J. Exp. Med. 204: 2277-2283.
55. Kajander, T., M. J. Lehtinen, S. Hyvärinen, A. Bhattacharjee, E. Leung, D. E. Isenman, S. Meri, A. Goldman, and T. S. Jokiranta. 2011. Dual interaction of factor H with C3d and glycosaminoglycans in host-nonhost discrimination by complement. Proc. Natl. Acad. Sci. USA 108: 2897-2902.
56. Sharma, A. K., and M. K. Pangburn. 1996. Identification of three physically and functionally distinct binding sites for C3b in human complement factor H by deletion mutagenesis. Proc. Natl. Acad. Sci. USA 93: 10996-11001.
57. Kühn, S., and P. F. Zipfel. 1996. Mapping of the domains required for decay acceleration activity of the human factor H-like protein 1 and factor H. Eur. J. Immunol. 26: 2383-2387.
58. Blackmore, T. K., J. Hellwage, T. A. Sadlon, N. Higgs, P. F. Zipfel, H. M. Ward, and D. L. Gordon. 1998. Identification of the second heparin-binding domain in human complement factor H. J. Immunol. 160: 3342-3348.
59. Blaum, B. S., J. P. Hannan, A. P. Herbert, D. Kavanagh, D. Uhŕin, and T. Stehle. 2015. Structural basis for sialic acid-mediated self-recognition by complement factor H. Nat. Chem. Biol. 11: 77-82.
60. Morgan, H. P., C. Q. Schmidt, M. Guariento, B. S. Blaum, D. Gillespie, A. P. Herbert, D. Kavanagh, H. D. Mertens, D. I. Svergun, C. M. Johansson, et al. 2011. Structural basis for engagement by complement factor H of C3b on a self surface. Nat. Struct. Mol. Biol. 18: 463-470.
61. Józsi, M., and P. F. Zipfel. 2008. Factor H family proteins and human diseases. Trends Immunol. 29: 380-387.
62. Ling, Q., A. T. Jacovina, A. Deora, M. Febbraio, R. Simantov, R. L. Silverstein, B. Hempstead, W. H. Mark, and K. A. Hajjar. 2004. Annexin II regulates fibrin homeostasis and neoangiogenesis in vivo. J. Clin. Invest. 113: 38-48.